FIGS, Inc. (FIGS) - Stock Analysis
Last updated: Apr 5, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Short-term momentum with fresh catalysts: Q4/FY25 delivered ~33% YoY revenue growth and an EPS beat ($0.10 vs $0.02), sparking a ~45% 21âday rally and new 52âweek highs. Price still trades ~9% above its 21âday SMA with a clear uptrend; a break above the 17.12 recent peak would likely trigger further buying as investors digest the beat and improving margin commentary over the coming sessions.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong liquidity ⢠Low leverage ⢠High SG&A burden FIGS has strong liquidity, low leverage and high gross margins, but outsized SG&A compresses operating profit and the stock trades at rich multiples versus modest net income and cash flow.
Price Behavior
Key Price Behavior Insights: ⢠Below last month SMA ⢠Recent >10% pullback ⢠Support holding near $14.2â$14.4 Support Level: $14.21â$14.40 Resistance Level: $16.00â$17.00 FIGS is trading below its last month SMA (~$15.11) at $14.66 after a ~13.6% pullback from $16.97, signaling short-term weakness with support near $14.21â$14.40 and resistance around $16.00â$17.00.
Sentiment & News
Key News Insights: ⢠Analyst upgrades ⢠Momentum signals ⢠Policy engagement FIGS attracted concentrated buy-side momentum and analyst upgrades in late March 2026, showed relative outperformance versus retail peers, and signaled public-policy engagement via support for the Healthcare is Human Act.
AI Summary
FIGS has shifted from a pure growth story to a cash-generative niche brand with durable gross margins, but its investment case now hinges on proving sustained operating leverage (converting high gross margin into recurring >9â10% operating margin) rather than topline alone. Investors should hold/watch and specifically watch for repeated margin expansion, clear tariff mitigation/sourcing progress, and no material inventory markdownsâfailure on those fronts would rapidly compress the rich valuation.
Description
FIGS, Inc. is a U.S.-based direct-to-consumer retailer of healthcare apparel and related lifestyle pieces, producing clinical garments and complementary outerwear, performance items and accessories. The company sells primarily through its website and mobile app. FIGS was founded in 2013 and is headquartered in Santa Monica, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Mar 13 | Mar 20 | FIGS | FIGS, Inc. | Short-term momentum with fresh catalysts: Q4/FY25 delivered ~33% YoY revenue growth and an EPS beat ($0.10 vs $0.02), sparking a ~45% 21âday rally and new 52âweek highs. Price still trades ~9% above its 21âday SMA with a clear uptrend; a break above the 17.12 recent peak would likely trigger further buying as investors digest the beat and improving margin commentary over the coming sessions. | Closed | -4.3% |